Journals / Türk Oftalmoloji Dergisi / 2020 / Cilt: 50 - Sayı: 6

Evaluation of Periorbital Tissues in Obstructive Sleep Apnea Syndrome

Obstrüktif Uyku Apne Sendromunda PeriorbitalDokuların Değerlendirilmesi

Pages
356–361
Publication Date
2022-11-06
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The mean vertical and anterior distraction distances in Group 1 (13.3±4.1 [range, 6-27] mm and 7.4±2.1 [range, 3-13.5]mm, respectively) were significantly higher than in Group 2 (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: To evaluate periorbital tissue alterations including eyelid laxity and eyelash ptosis in patients with obstructive sleep apneasyndrome (OSAS).
📊
Key Findings & Data:Materials and Methods: Based on polysomnography, 96 eyes of 48 patients with moderate/severe OSAS (Group 1) and 44 eyes of 22patients with simple snoring (Group 2) were enrolled.
💡
Conclusion & Impact:The mean vertical and anterior distraction distances in Group 1 (13.3±4.1 [range, 6-27] mm and 7.4±2.1 [range, 3-13.5]mm, respectively) were significantly higher than in Group 2 (p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objectives: To evaluate periorbital tissue alterations including eyelid laxity and eyelash ptosis in patients with obstructive sleep apneasyndrome (OSAS). Materials and Methods: Based on polysomnography, 96 eyes of 48 patients with moderate/severe OSAS (Group 1) and 44 eyes of 22patients with simple snoring (Group 2) were enrolled. Comprehensive eye examination along with eyelid laxity measurements includingvertical and anterior distraction, presence of dermatochalasis, interpalpebral distance, and levator function were assessed. The presenceand severity of eyelash ptosis were also noted. Results: The mean ages of Group 1 and Group 2 were 49.9±11.4 (range: 26-67) and 50.6±8.9 (range: 27-69) years, respectively(p=0.557). The mean vertical and anterior distraction distances in Group 1 (13.3±4.1 [range, 6-27] mm and 7.4±2.1 [range, 3-13.5]mm, respectively) were significantly higher than in Group 2 (p

Özet

Amaç: Obstrüktif uyku apne sendromu (OUAS) olan hastalarda kapak laksitesi, kirpik ptozisi gibi periorbital dokularda gelişen değişikliklerin değerlendirilmesi amaçlandı.Gereç ve Yöntem: Polisomnografi sonucuna göre orta veya ağır OUAS tanısı almış (Grup 1) 48 hastanın 96 gözü ve basit horlama tanısı almış (Grup 2) 22 hastanın 44 gözü çalışmaya dahil edildi. Detaylı oftalmolojik muayeneyle birlikte, hastalarda kapak laksitesinin değerlendirilmesine yönelik vertikal ve anterior distraksiyon mesafeleri, dermatoşalazis varlığı, interpalpebral mesafe, levator kas fonksiyonu ölçüldü. Kirpik ptozisi varlığı ve eğer var ise derecesi kaydedildi.Bulgular: Hastaların ortalama yaşı Grup 1 ve 2’de sırasıyla 49,9±11,4 (aralık: 26-67) ve 50,6±8,9 (aralık: 27-69) idi (p=0,557). Vertikal ve anterior distraksiyon mesafeleri, Grup 1’de sırasıyla 13,3±4,1 yıl (aralık: 6-27) mm ve 7,4±2,1 yıl (aralık: 3-13,5) mm olup Grup 2’ye kıyasla anlamlı olarak daha yüksek saptandı (p

🔖

Cite This Article

KARACA, I., PALAMAR, M., YAĞCI, A., TAŞBAKAN, M. S., BAŞOĞLU, Ö. K. (2022). Evaluation of Periorbital Tissues in Obstructive Sleep Apnea Syndrome. Türk Oftalmoloji Dergisi, Cilt: 50 - Sayı: 6, 356–361. https://ajindex.com/articles/637661

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (18)

  1. Guilleminault C, Tilkian A, Dement WC. The sleep apnea syndromes. Annu Rev Med. 1976;27:465-484
  2. Lee W, Nagubadi S, Kryger MH, Mokhlesi B. Epidemiology of Obstructive Sleep Apnea: a Population-based Perspective. Expert Rev Respir Med. 2008;2:349-364
  3. Finkel KJ, Searleman AC, Tymkew H, Tanaka CY, Saager L, Safer-Zadeh E, Bottros M, Selvidge JA, Jacobsohn E, Pulley D, Duntley S, Becker C, Avidan MS. Prevalence of undiagnosed obstructive sleep apnea among adult surgical patients in an academic medical center. Sleep Med. 2009;10:753-758
  4. Myers KA, Mrkobrada M, Simel DL. Does this patient have obstructive sleep apnea? The Rational Clinical Examination systematic review. JAMA. 2013;310:731-741
  5. Peppard PE, Young T, Barnet JH, Palta M, Hagen EW, Hla KM. Increased prevalence of sleep-disordered breathing in adults. Am J Epidemiol. 2013;177:1006-1014
  6. Young T, Evans L, Finn L, Palta M. Estimation of the clinically diagnosed proportion of sleep apnea syndrome in middle-aged men and women. Sleep. 1997;20:705-706
  7. Kohler M, Stradling JR. Mechanisms of vascular damage in obstructive sleep apnea. Nat Rev Cardiol. 2010;7:677-685
  8. Kohler M. Deleterious systemic effects of OSA: how much evidence do we need? Thorax. 2015;70:817-818
  9. Stansbury RC, Strollo PJ. Clinical manifestations of sleep apnea. J Thorac Dis. 2015;7:E298-E310
  10. Dhillon S, Shapiro CM, Flanagan J. Sleep-disordered breathing and effects on ocular health. Can J Ophthalmol. 2007;42:238-243
  11. Woog JJ. Obstructive sleep apnea and the floppy eyelid syndrome. Am J Ophthalmol. 1990;110:314-315
  12. Culbertson WW, Ostler HB. The floppy eyelid syndrome. Am J Ophthalmol. 1981;92:568-575
  13. Mojon DS, Hess CW, Goldblum D, Fleischhauer J, Koerner F, Bassetti C, Mathis J. High prevalence of glaucoma in patients with sleep apnea syndrome. Ophthalmology. 1999;106:1009-1012
  14. Mojon DS, Mathis J, Zulauf M, Koerner F, Hess CW. Optic neuropathy associated with sleep apnea syndrome. Ophthalmology. 1998;105:874-877
  15. Purvin VA, Kawasaki A, Yee RD. Papilledema and obstructive sleep apnea syndrome. Arch Ophthalmol. 2000;118:1626-1630
  16. Waller EA, Bendel RE, Kaplan J. Sleep disorders and the eye. Mayo Clin Proc. 2008;83:1251-1261
  17. Leveque TK, Yu L, Musch DC, Chervin RD, Zacks DN. Central serous chorioretinopathy and risk for obstructive sleep apnea. Sleep Breath. 2007;11:253-257
  18. Glacet-Bernard A, Leroux les Jardins G, Lasry S, Coscas G, Soubrane G, Souied E, Housset B. Obstructive